Answers are grounded in this paper and cite their sources.
Purpose Early positron emission tomography–derived metrics post–oligometastasis radioablation may predict impending local relapses (LRs), providing a basis for a timely ablation. Methods and Materials Positron emission tomography data of 623 lesions treated with either 24 Gy single-dose radiation therapy (SDRT) (n = 475) or 3 × 9 Gy stereotactic body radiation therapy (SBRT) (n = 148) were analyzed in a training data set (n = 246) to obtain optimal cutoffs for pretreatment maximum standardized uptake value (SUV max ) and its 3-month posttreatment decline (ΔSUV max ) in predicting LR risk, validated in a data set unseen to testing (n = 377). Results At a median of 21.7 months, 91 lesions developed LRs: 39 of 475 (8.2%) after SDRT and 52 of 148 (35.1%) after SBRT. The optimal cutoff values were 12 for SUV max and –75% for ΔSUV max . Bivariate SUV max /ΔSUV max permutations rendered a 3-tiered LR risk stratification of dual-favorable (low risk), 1 adverse (intermediate risk) and dual-adverse (high risk). Actuarial 5-year local relapse-free survival rates were 93.9% versus 89.6% versus 57.1% ( P < .0001) and 76.1% versus 48.3% versus 8.2% ( P < .0001) for SDRT and SBRT, respectively. The SBRT area under the ROC curve was 0.71 (95% CI, 0.61-0.79) and the high-risk subgroup yielded a 76.5% true positive LR prediction rate. Conclusions The SBRT dual-adverse SUV max /ΔSUV max category LR prediction power provides a basis for prospective studies testing whether a timely ablation of impending LRs affects oligometastasis outcomes.
No takes yet. Share an insight, caveat, or question.
Greco et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: